October 23, 2024

ImmuneWatch is attending SITC 2024

ImmuneWatch will be attending the Society for Immunotherapy of Cancer (SITC) Annual Meeting in Houston from November 6–8.

Our CEO Sander Wuyts, will be there sharing insights on how our machine learning tools, like ImmuneWatch DETECT, can help you find the specificity of your T-Cell receptors.

If you’re also attending and would like to explore how we can help optimise your immune-monitoring strategies, feel free to reach out. We're always open to discussing innovative solutions for advancing cancer immunotherapies.

Request a meeting at SITC

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

July 29, 2024

New academic paper: Discovering the Link Between T Cell Receptor Diversity and Herpes Zoster Risk

In a new study led by ImmuneWatch co founders, Prof. Kris Laukens, Prof. Pieter Meysman and Prof. Benson Ogunjimi at the University of Antwerp, researchers have unveiled new insights into how the diversity of T cell receptors (TCRs) influences susceptibility to herpes zoster (HZ), commonly known as shingles.

October 14, 2024

ImmuneWatch DETECT Assists in Uncovering the Role of CMV in T-Cell Leukemia

Recently, our DETECT tool played a role in research conducted by Dr. Utpal Davé, Associate Professor at Indiana University School of Medicine, aimed at understanding T-cell large granular lymphocytic leukemia (T-LGL).